Biogen (BIIB) Tops Q3 EPS by 22c

October 26, 2016 7:00 AM EDT
Get Alerts BIIB Hot Sheet
Trade BIIB Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Biogen (NASDAQ: BIIB) reported Q3 EPS of $5.19, $0.22 better than the analyst estimate of $4.97. Revenue for the quarter came in at $2.96 billion versus the consensus estimate of $2.91 billion.

Eloctate revenue $131.8 million, est. $131.2 million.
Alprolix revenue $85.2 million, est. $86.2 million.

For earnings history and earnings-related data on Biogen (BIIB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Hot Earnings

Related Entities

Earnings

Add Your Comment